Pediatric Prehospital Airway Resuscitation Trial
Launched by OHIO STATE UNIVERSITY · Apr 11, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Pediatric Prehospital Airway Resuscitation Trial is a clinical study aimed at finding the best ways to manage airways in critically ill children who experience life-threatening situations like heart arrest or severe injuries. The trial involves different strategies that emergency medical teams can use, such as providing breathing support with a bag-mask (BVM) alone, using a bag-mask followed by a supraglottic airway (SGA), or a bag-mask followed by endotracheal intubation (ETI). The main goal of the study is to see which method helps children survive without needing intensive care for 30 days.
To participate in this trial, children must be aged between 24 hours and 17 years old and require emergency treatment for conditions like cardiac arrest, major trauma, or breathing difficulties. Unfortunately, children who have a tracheostomy, those who are pregnant, or those whose airway management is already being handled by a non-study EMS agency cannot take part. If eligible, participants will receive one of the airway management strategies during an emergency call, and the trial is designed to gather data to determine the most effective approach. This study aims to improve emergency care for children in critical situations and is currently recruiting participants.
Gender
ALL
Eligibility criteria
- Inclusion criteria are:
- • At least 24 hours old and \<18 years old
- • Cardiopulmonary arrest, major trauma or respiratory failure
- • Life-saving care initiated or continued by Pedi-PART EMS personnel as part of an emergency "9-1-1" response
- • Requiring active airway management (BVM or higher level of respiratory support
- Exclusion criteria are:
- • Prisoners
- • Pre-existing tracheostomy
- • Pre-existing do-not-resuscitate/do-not-intubate status
- • Visibly or known to be pregnant
- • Initial advanced airway attempt by an EMS agency not affiliated with the study
- • Interfacility transports
- • EMS personnel will use bystander reports or follow local protocols to establish patient age and pregnancy status.
About Ohio State University
The Ohio State University (OSU) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a commitment to improving patient care and outcomes, OSU leverages its extensive resources, interdisciplinary collaboration, and expertise in diverse medical fields. The university fosters an environment of rigorous scientific inquiry, ensuring that clinical trials are conducted with the highest ethical standards and adherence to regulatory guidelines. Through its Clinical Trials Office, OSU aims to translate groundbreaking research into practical applications, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milwaukee, Wisconsin, United States
Sacramento, California, United States
Indianapolis, Indiana, United States
Washington, District Of Columbia, United States
Columbus, Ohio, United States
Tucson, Arizona, United States
Los Angeles, California, United States
Aurora, Colorado, United States
Charlotte, North Carolina, United States
Austin, Texas, United States
Patients applied
Trial Officials
Henry E Wang, MD, MS
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported